HNHacker News
TopNewBestAskShowJobs

hkiely

37 karma · joined August 16, 2013

Interests Healthcare, biotechnology, health policy, startups, investing, building things, cooking, traveling, and design
submissionscomments
hkiely··on Ask HN: Is there an HN type site focused on medical news?
Over the years many people have tried building sites like this. None of them have ever worked out.
hkiely··on Ask HN: What should be the point of being rich?
Why would anyone work a paying job if all of these necessities were provided to us? Wouldn't an individual choose to peruse a passion or educational / research goal full time, rather than possibly working a job he or she didn't like but need to pay the bills?
hkiely··on Pharmacy Startup PillPack Could Change the Way America Takes Its Medicine
Regardless of the company's ambition, the firm still has to compete with all of the other small businesses marketing the same packaging services in every city. Many actually have very similar machines manufactured by AmerisourceBergen.

The role of a PBM is to create value for the payer; this typically occurs by the company using the collective power of its membership to negotiate down drug prices, specialty or otherwise. If creating value for the payer means increasing adherence then why not. At least that's what many PBM executives have said that I have spoken with.

The largest customer is the pbm/ payer/ private insurer market where the benefits of adherence can be marketed to those who pay for the cost of patient noncompliance.

I had a project very similar to this. However, my focus was the backend data system as my perspective was each patient may need a different compliance solution.

hkiely··on Ask HN: What is your one tip about A/B testing you would share?
Choose and test one independent variable at a time. Then, check your results for statistical significance.
hkiely··on Thanks, HN: You helped discover a disease and save lives
Regardless if we can or can't manipulate our DNA with approaches such as gene therapy, we first must get therapeutics to patients with rare and orphan conditions in an adequate amount of time.

Many patients wait on the the hurdles set in place by the FDA who think they are protecting patients safety. However, with a quickly progressing illness and no treatment, often the patient will die without the drug that is being withheld.

The YouTube Video Shows Dr. Bill Gahl of the NIH Undiagnosed Diseases Program speaking at a TED event.

https://www.youtube.com/watch?v=aMMBmc_pQVA

hkiely··on Getting to No: The Key to Startup Selling
The key thing is to make sure you understand why the customer is saying no, or why they are saying yes. If you don't get a firm no you can never actually ask the questions that will let you understand where there is a mismatch between the potential customer and product. After understanding you can better alter the product or customer you go after.
hkiely··on PillPack Raises $4M in Bid to Become Top Mail-Order Pharmacy
Many senior care and mail order pharmacies use such machines.

http://www.thriftywhite.com/Healthy_Pack_Rx.cfm

https://medexpack.com/what-is-a-medex-pack/pre-sorted-indivi...

hkiely··on Snapchat Phone Number Database Leaked
It looks like they only bothered with most populated area codes.
hkiely··on Profit affects doctors' treatment decisions
The real way to solve this problem is to get the patients motivated and involved in their own care and treatment decisions. In a free market, driven by true choice, patients have the responsibility of learning more independently about their diagnosis, treatment options, and their physician. By doing research, a patient may be driven to get a second or third opinion when faced with a diagnosis like cancer. By utilizing healthcare savings accounts (HSA) and high deductible low premium insurance plans, patients are driven to find the best doctor with the lowest prices. This is how the invisible hand works, choice and competition on each side of the market. The result- A decrease in price and an increase in quality.
hkiely··on Show HN: We structured and compared hospital chargemaster prices
There are a few insurance companies like this. However, the patient must have the cash flow for these large expenses. It often takes takes time to get reimbursed.
hkiely··on Show HN: We structured and compared hospital chargemaster prices
No one pays chargemaster prices. The reason hospitals set the prices so high is because they are the starting point for negotiations with networks and insurance companies. Even consumers without insurance typically don't pay chargemaster prices as hospitals normally have cash pay discounts. As payers begin to contract with ACO's, I think we'll likely see a shift to a more standard shape bell curve if reform is working.
← PreviousPage 3 of 3